X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
GLENMARK PHARMACEUTICALS LIMITED Quarterly Results - Equitymaster
 
GLENMARK PHARMACEUTICALS LIMITED  - Last 8 Quarters  (GLPH)

Here are the latest quarterly results of Glenmark Pharma. For more details, see the Glenmark Pharma financial fact sheet and Glenmark Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.
 Interim Results
No. of Months
Qtr. Ending
3
Mar-15
*
3
Jun-15
*
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m17,75816,47718,74617,56422,81319,43122,24125,350 
Other income Rs m35482111775918146 
Turnover Rs m17,76116,53118,75417,58522,92920,19022,25925,496 
Expenses Rs m14,94412,88214,72813,86619,78615,64017,75317,700 
Gross profit Rs m2,8143,5964,0193,6983,0283,7914,4517,650 
Depreciation Rs m645697634559628642687625 
Interest Rs m397419426469475430629617 
Profit before tax Rs m1,7762,5332,9672,6922,0423,4773,1546,553 
Tax Rs m-2017519629923271,2099181,782 
Profit after tax Rs m1,9771,7822,0041,6991,7152,2682,2364,770 
Gross profit margin %15.821.821.421.113.319.520.030.2 
Effective tax rate %-11.329.632.436.916.034.829.127.2 
Net profit margin %11.110.810.79.77.511.710.118.8 
Diluted EPS Rs 7.3 6.6 7.4 6.3 6.3 8.4 8.2 17.6  
Diluted EPS (TTM) Rs 24.4 24.2 25.5 27.5 26.5 28.3 29.2 40.5  
 Subscriber Feature Our View Our View Our View Our View Our View Our View Our View Our View  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster



Today's Market

Sensex Trades Strong; Energy Stocks Witness Buying(01:30 pm)

After opening the day on a positive note, share markets in India have continued the momentum and are trading comfortably above the dotted line.

Views on news

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

Glenmark: Other Income Boosts Profit Growth (Quarterly Results Update - Detailed)

Sep 6, 2016

Glenmark has announced its 1QFY17 results. The company has reported 15.8% YoY growth in net sales and 24% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

More Views on News

Most Popular

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

Aur Bhi Dukh Hain Zamane Main Stock Market Ke Siva...(Vivek Kaul's Diary)

Apr 13, 2017

The link between the Indian economy and the stock market is weak, and the stock market is not a reflection of the Indian economy.

The Real Reason Indiabulls Real Estate Jumped 42%(Daily Profit Hunter)

Apr 19, 2017

An elephant and six blind men will tell you more about the markets than any financial newspaper or channel.

7 Benefits Of Creating A CAN(Outside View)

Apr 13, 2017

The MFU platform offers ease, convenience, and speed of transacting in various mutual fund schemes.

More

GLENMARK PHARMA SHARE PRICE


Apr 25, 2017 03:33 PM

TRACK GLENMARK PHARMA

  • Track your investment in GLENMARK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GLENMARK PHARMA

GLENMARK PHARMA - AUROBINDO PHARMA COMPARISON

Compare Company With Charts

COMPARE GLENMARK PHARMA WITH

MARKET STATS